Regeneron Pharmaceuticals Earnings Preview
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $9.92. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $739.07, up 19.85% over the last 52-week period.
August 04, 2023 | 11:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals is expected to release its earnings report, with an estimated EPS of $9.92. The company's history of beating EPS estimates could potentially lead to a positive impact on its share price.
Regeneron Pharmaceuticals has a history of beating EPS estimates, which has generally led to an increase in its share price. If the company beats the estimated EPS of $9.92, it could potentially lead to a positive impact on its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100